28
May 2026
When a person loses a limb, a prosthesis often can help restore a significant degree of mobility. But when movement or communication is impaired by a neurological condition such as amyotrophic lateral sclerosis (ALS), spinal cord injury or stroke, there are, as of yet, very few options for the affected individual.
28
May 2026
Diagnostic interviews are widely used by mental health professionals to identify conditions such as anxiety, bipolar disorder and depression in adults, but new research led by McMaster University shows that the long considered "gold standard" may not be as consistent as previously thought.
28
May 2026
A Mount Sinai-led research team has demonstrated that autoimmunity, where the body's immune system attacks its own tissues, is responsible for the often-debilitating and confounding symptoms of long COVID in a subset of people.
28
May 2026
Chronic oral inflammation may impair female fertility by triggering a systemic immune response that affects the ovaries.
28
May 2026
As more people turn to artificial intelligence chatbots for emotional and mental health support, a new study from Drexel University suggests that most users see these tools as supplements to - not substitutes for - human therapy.
28
May 2026
Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease.
28
May 2026
Researchers from the University of Cambridge highlight new ways that neurons and many cell types use to sense nutrients - opening potential novel therapeutic avenues for disorders such as Alzheimer's and Parkinson's disease.
28
May 2026
Researchers with the University of Cincinnati and Johns Hopkins Medicine developed a potential treatment for brain cancer that uses nanofibers embedded with a combination of drugs that work in concert to target tumors.
28
May 2026
A new study from Wake Forest University School of Medicine suggests a routine heart test – an electrocardiogram (ECG) – may offer researchers a new way to measure biological development in children and adolescents.
28
May 2026
Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute, part of the National Institutes of Health, to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults (AYAs).
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
